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Commentary
Interleukin-4 receptor α gene variants and allergic disease
Ian P Hall
University Hospital of Nottingham, Nottingham, UK
Abstract
The interleukin-4 (IL-4) signalling cascade has been identified as a pathway potentially
important in the development of asthma. Genetic variants within this signalling pathway
might contribute to the risk of developing asthma in a given individual. A number of
polymorphisms have been described within the IL-4 receptor α (IL-4Rα) gene. In addition
polymorphism occurs in the promoter for the IL-4 gene itself. This commentary accompanies
a paper by C Ober et al describing the contribution of IL-4Rα polymorphism to susceptibility
to asthma and atopy in the Hutterite population and other outbred populations collected
during the collaborative studies on the genetics of asthma (CSGA) programme.
Keywords: asthma atopy, genetics, interleukin-4, interleukin-13
Received: 14 April 2000
Revisions requested: 8 May 2000
Revisions received: 30 May 2000
Accepted: 30 May 2000
Published: 23 June 2000
Respir Res 2000, 1:6–8
The electronic version of this article can be found online at
http://respiratory-research.com/content/1/1/006
© Current Science Ltd (Print ISSN 1465-9921; Online ISSN 1465-993X)
CSGA = collaborative studies on the genetics of asthma; IL = interleukin; IL-4Rα = IL-4 receptor α; SNP = single nucleotide polymorphism.
http://respiratory-research.com/content/1/1/006
Several genome-wide screens have now been performed
in different populations, looking for susceptibility genes for
asthma and allergic disease. In general, the results of
these genome screens have been somewhat disappoint-
ing in that, although chromosomal regions showing
linkage have been identified, the strength of linkage at any
given site has been inconsistent. These data suggest that
a number of genes of moderate effect rather than a small
number of genes with marked effects contribute to the
genetic basis of allergic disease.
To try to dissect out the important candidate genes that
contribute to the risk of developing asthma or its important
sub-phenotypes, several groups have concentrated on
strong candidate genes that map to known susceptibility
loci for asthma and atopy. Several such candidates have
been identified (Table 1), including the gene for inter-
leukin-4 receptor α (IL-4Rα), which is situated on chromo-
some 16p and is known to contain a number of
polymorphisms. The recent paper from Carole Ober and
colleagues [1] provides important information on the
potential relevance of IL-4Rα gene variants in determining
the risk of developing atopic disease.
The IL-4Rα subunit forms part of the signalling complex
for IL-4 itself but also serves as the α chain of the IL-13
receptor. Both IL-4 and IL-13 themselves have been impli-
cated as potential candidate genes in the development of
asthma, both being present in the TH2 cytokine locus on
chromosome 5q23–31 [2]. Both IL-4 and IL-13 have over-
lapping functions, including mediating isotype switching to
IgE synthesis.
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Several previous studies have suggested association
and/or linkage between IL-4Rα gene variants and allergic
disease, although not all studies have been positive. Mit-
suyasu et al [3] reported the Ile50 allele of the IL-4Rα to
be associated with atopic asthma, whereas Kruse et al [4]
reported an association between the Pro478 and Arg551
alleles and low IgE levels. Hershey et al [5] reported an
association between the Arg551 allele and IgE levels and
atopic dermatitis. Functional evidence for the importance
of these polymorphisms has been obtained with assays of
signal transduction in vitro [3,5,6]. Several other amino
acid polymorphisms have been reported within this gene,
although good functional evidence supporting their impor-
tance has not yet been obtained [7].
Ober’s study provides important additional information on
the potential role of the IL-4Rα in allergic disease [1]. In
this study, all known SNPs (single nucleotide polymor-
phisms) within the IL-4Rα locus were genotyped in the
South Dakota Hutterite population (in whom a chromo-
some 16 susceptibility locus has already been identified),
and also in ethnically diverse outbred populations col-
lected as part of the CSGA [8]. The major findings of this
study were that all the population samples studied
showed evidence of association to markers of atopy or
asthma per se for different alleles within this locus, but the
haplotypes with the best evidence for association differed
between the populations. These data suggest that the true
disease susceptibility allele (if one exists) remains to be
identified, or alternatively that different haplotypes in differ-
ent populations might confer risk. In favour of the first
explanation, a careful haplotype analysis (ie an examination
of combinations of polymorphisms rather than the poly-
morphisms in isolation) suggested that the true suscepti-
bility locus might depend on additional variation outside
the coding region of the IL-4Rα gene itself.
An important finding from this study that has wider impli-
cations in the study of asthma genetics is the finding that
different haplotypes showed the strongest evidence for
association in different ethnic groups. When a candidate
gene contains a number of polymorphisms these are
usually in tight linkage disequilibrium because of the rela-
tively small genetic distances between the polymorphisms.
Hence it can be difficult in a single population to dissect
out the important polymorphism, in other words that which
actually confers susceptibility to a given disease at a given
locus. The IL-4Rα subunit gene is not unique in having a
large number of polymorphisms within its coding region.
Several other candidate genes, which might be important
in allergic disease, also demonstrate quite marked poly-
morphic variation; the best example is perhaps the β2
adrenoceptor locus on chromosome 5q31–33, which
contains at least 17 SNPs within a region of approx. 3 kilo-
bases containing the gene and important 5′ and 3′ flank-
ing regions [9,10]. Another important observation in
Ober’s study is that even in an inbred population such as
the Hutterites, with relatively few founders and recent
origins [11], potentially important association would have
been missed by the use of evenly spaced SNPs across
the genome at the density currently being proposed for
use by the SNP consortium. It might be that the use of
multiple SNPs in strong candidate genes for association-
based studies is the best way forward for determining the
effect of variants that have small or moderate effects on
disease risk, as has previously been suggested [12,13].
Another possibility worthy of further study is that combina-
tions of variants in a number of components of a signalling
pathway might overall provide an important risk factor for
disease susceptibility. For IL-4 it would be reasonable to
believe that polymorphisms that increase the level of
expression of IL-4 itself might interact with polymorphisms
altering the binding of IL-4 to the receptor and/or signalling
of the receptor. Additional polymorphisms in the down-
stream signalling pathways could also contribute to the
overall response to produce ‘high’ and ‘low’ IL-4 respon-
sive phenotypes. Some evidence that IL-4 promoter poly-
morphisms might contribute to levels of IL-4 expression in
allergic disease has already been described [14] and it will
be interesting to look for interactions between these poly-
morphisms and polymorphisms of the IL-4Rα subunit.
In summary, the paper by Ober et al suggests that a
locus near the IL-4Rα gene determines a susceptibility
gene for the development of asthma and atopy both in the
Hutterite population and in other outbred populations.
However, despite a number of clinical studies and func-
tional studies on signalling of the receptor in vitro, the
most important polymorphisms at this locus still remain to
be determined, and additional studies concentrating on
different components of the relevant signalling cascade
need to be performed.
Table 1
Chromosomal candidate regions in asthma and atopy
Chromosome Candidate genes
5q23–31 Interleukin-4, interleukin-5, interleukin-9, interleukin-13
5q31–33 β2 adrenoceptor
6p HLA complex including tumour necrosis factor-α
11q13 FcεR1β
12q Interferon-α
NO synthase
Mast cell growth factor
14q T cell receptor
16 Interleukin-4 receptor α
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